65 filings
Page 3 of 4
8-K
7xvepn7y9cab
16 May 22
Results of Operations and Financial Condition
6:34pm
8-K
0ze46f1m8ir
6 May 22
Changes in Registrant's Certifying Accountant
4:05pm
8-K/A
3dow3rz8 hozu7
22 Apr 22
Index to Financial Statements
5:21pm
8-K/A
feo3gvri bxo
15 Apr 22
Index to Financial Statements
5:27pm
8-K
ak5sqh4zstf2do 8de
15 Mar 22
Developing innovative therapeutics and diagnostics to address unmet needs Corporate Presentation / March 2022 www.revbiosciences.com
3:09pm
8-K
j7wmr
11 Feb 22
Developing innovative therapeutics and diagnostics to address unmet needs Corporate Presentation / February 2022 www.revbiosciences.com
12:00am
8-K
b78 h296o9ze19cqmw8
27 Jan 22
Entry into a Material Definitive Agreement
4:05pm
8-K
54jtp
14 Jan 22
Completion of Acquisition or Disposition of Assets
4:28pm
8-K
wd6mr0p
13 Jan 22
Developing innovative therapeutics and diagnostics to address unmet needs Corporate Presentation / January 2022
3:53pm
8-K
wky0u6sd59mpm 1t9
12 Jan 22
Amendments to Articles of Incorporation or Bylaws
4:49pm
8-K
20v wawhzx0
23 Dec 21
Petra Acquisition, Inc. Announces Share Redemption Backstop and Forward Purchase Agreements in Revelation Biosciences, Inc. Business Combination
5:27pm
8-K
7xkrnbuutkowpjr614
17 Dec 21
Other Events
3:31pm
8-K
flbnjxanp26rkvhjhu9
24 Nov 21
Other Events
5:17pm
8-K
dyst3iyzo71beoo3
19 Oct 21
Entry into a Material Definitive Agreement
5:23pm
8-K
gmfg9og012q2hkf
13 Oct 21
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
rkxcvcsnyo0f4nl
23 Sep 21
Entry into a Material Definitive Agreement
5:22pm
8-K
kamzv
2 Sep 21
Entry into a Material Definitive Agreement
5:11pm
8-K
xmk nshi3sy8
31 Aug 21
Regulation FD Disclosure
6:06am
8-K
ejijm9wlh04r6ezm1fo
16 Jun 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:43pm
8-K
voqc72e yn7
1 Jun 21
Petra Acquisition, Inc. Receives Expected Nasdaq Notification Regarding Delayed Form 10-Q
4:31pm